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Abstract
Background: In patients submitted to major pulmonary resection, the postoperative length of stay is mainly
influenced by the duration of air leaks and chest tube removal. The measurement of air leaks largely relies on
traditional chest drainage systems which are prone to subjective interpretation. Difficulty in differentiating between
active air leaks and bubbles due to a pleural space effect may also lead to tentative drain clamping and prolonged
time for chest drain removal. New digital systems allow continuous monitoring of air leaks, identifying subtle leakage
that may be not visible during daily patient evaluation. Moreover, an objective assessment of air leaks may lead to a
reduced interobserver variability and to an optimized timing for chest tube removal.
Methods: This study is a prospective randomized, interventional, multicenter trial designed to compare an electronic
chest drainage system (Drentech™ Palm Evo) with a traditional system (Drentech™ Compact) in a cohort of patients
undergoing pulmonary lobectomy through a standard three-port video-assisted thoracic surgery approach for both
benign and malignant disease. The study will enroll 382 patients in three Italian centers. The duration of chest drainage
and the length of hospital stay will be evaluated in the two groups. Moreover, the study will evaluate whether the use
of a digital chest system compared with a traditional system reduces the interobserver variability. Finally, it will evaluate
whether the digital drain system may help in distinguishing an active air leak from a pleural space effect, by the digital
assessment of intrapleural differential pressure, and in identifying potential predictors of prolonged air leaks.
Discussion: To date, few studies have been performed to evaluate the clinical impact of digital drainage systems.
The proposed prospective randomized trial will provide new knowledge to this research area by investigating and
comparing the difference between digital and traditional chest drain systems. In particular, the objectives of this
project are to evaluate the feasibility and usefulness of digital chest drainages and to provide new tools to identify
patients at higher risk of developing prolonged air leaks.
Trial registration: ClinicalTrials.gov, NCT03536130. Retrospectively registered on 24 May 2018.
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Background
Length of stay (LOS) impacts significantly on health-
care costs. In patients submitted to major pulmonary re-
section, the LOS is mainly influenced by the duration of
air leaks and chest tube removal, which are the main fac-
tors that delay hospital discharge. Prolonged air leaks
affect between 10 and 15% of pulmonary surgical proce-
dures and may be a risk factor for increased morbidity,
prolonged hospital stay and increased costs [1, 2]. The
measurement or grading of air leaks still relies on a
static analog measurement of “bubbles in a chamber”
using traditional chest drainage systems. These systems
are inherently prone to subjective interpretation and ob-
server variability conditioned by habit and personal
clinical experience [3]. Moreover, the difficulty in differ-
entiating between an active air leak and bubbles due to a
pleural space effect, which are indistinguishable on
checking a traditional water-seal chest drain system, may
lead to tentative drain clamping and prolonged time for
chest drain removal.
The introduction of novel digital chest drainage sys-
tems could give specific advantages.
First of all, they could give an objective assessment of
real air leak, reduce interobserver variability and, finally,
optimize the timing of chest tube removal. Continuous
monitoring of air leaks may identify subtle leakage that
may not be visible during daily patient evaluation. More-
over, these systems could distinguish an active air leak
from an apparent air leak due to a pleural space effect
through the evaluation of differential intrapleural pres-
sures [4]. Finally, these systems could identify patients at
higher risk of prolonged air leak and this could be useful
in prompting either early active intervention or conver-
sion to a one-way valve system that would allow for out-
patient management and therefore early discharge from
the hospital [5]. Some of these systems feature portable
suction systems, allowing earlier mobilization of the pa-
tients, thus reducing complications due to bed immobil-
ity. To date, few studies (mostly single-center studies
with small numbers of patients) have been performed
with the aim to evaluate the clinical impact of digital
drainage systems [5, 6]. The works published on this
subject were performed using different electronic de-
vices: some of them use an air flow meter to directly
measure the airflow through the chest tube, whereas
others derive these data from an algorithm based on the
intrapleural pressure maintained by a suction pump and
measured through a pressure sensor [5, 7, 8].
These previous studies proved that electronic drainage
systems contribute to early mobilization, shorten the
duration of chest tube placement, and thus hospital stay,
and reduce costs using a more accurate and objective air
leak assessment. Moreover, these systems are more ef-
fective in standardizing postoperative management of
chest tubes [6, 7]. These advantages have particular im-
portance in patients undergoing pulmonary resection
with an underlying pulmonary disease such as COPD
[9]. Finally, another possible advantage is to avoid tenta-
tive clamping since digital drainage eliminates subjective
estimation. Brunelli et al. [5] described the possibility of
predicting the risk of prolonged air leak after pulmonary
lobectomy through the analysis of both air leak flow and
pleural pressure. Such analysis cannot obviously be
performed through a standard water-seal chest drain
system.
All of these studies underlined the potential clinical
utility and impact of electronic drainage systems; how-
ever, prospective randomized studies with a large num-
ber of patients are needed to corroborate these results.
Therefore, we intend to perform a trial to compare
electronic chest drainage system performances to those
of a traditional system in a prospective cohort of patients
who received thoracoscopic lobectomy. Both systems are
currently used in our daily clinical practice.
Primary outcomes
 To determine whether the use of a digital chest
system compared with a traditional system reduces
the duration of chest drainage and LOS
Primary outcome measures
To determine whether the use of a digital chest system
compared with a traditional system reduces the duration
of chest drainage and LOS, and to evaluate the role of
interobserver variability, the duration of chest tube stay,
the hospital length of stay and the daily presence of
active air leaks will be evaluated in the two groups.
Secondary outcomes
 To quantify the variability of results regarding the
subjective observer evaluation of active air leaks
(through the traditional system) compared with the
objective data registered by the digital system
 To distinguish an active air leak from a pleural space
effect by the evaluation of intrapleural differential
pressure
 To identify potential predictors of prolonged air
leaks
Secondary outcome measures
To distinguish an active air leak from a pleural space ef-
fect and to identify potential predictors of prolonged air
leaks, the digital chest system will record and evaluate
the intrapleural differential pressure, the flow of air leaks
and the daily variation of these two parameters in each
patient.
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Methods/design
This study is designed as a prospective randomized,
multicenter, investigator-initiated study, of an interven-
tional type, performed at three high-volume Italian
thoracic surgery units: Thoracic Surgery Unit of Padua
University Hospital, Thoracic Surgery Unit of Fondazione
IRCCS Cà Granda Ospedale Maggiore Policlinico—
University of Milan and Thoracic Surgery Unit of Vito
Fazzi Hospital, Lecce.
This protocol is reported in line with the Standard
Protocol Items: Recommendations for Interventional
Trials (SPIRIT) guidelines using the SPIRIT figure
(Fig. 1), trial flow chart (Fig. 2) and SPIRIT Checklist
(Additional file 1).
The study will enroll 382 patients undergoing pulmonary
lobectomy through a standard uniportal, biportal or tripor-
tal VATS approach, either for benign or malignant disease.
The sample size was calculated considering a two-
sided t test for a difference in means outcome, according
to the following assumptions: effect size = 0.33 for both
primary endpoints, power (1 – β) = 0.8 and α = 0.025
accounting for a Bonferroni adjustment (α = 0.05 / 2)
[10]. The sample size computation was performed with
R software [11].
Fig. 1 Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) figure for the schedule of enrollment, interventions and
assessments. CT computed tomography, ECG electrocardiogram, PET positron emission tomography
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Potential participants will be identified and recruited
into the trial by surgeons who work in the aforemen-
tioned thoracic surgery units.
Patients will be enrolled if they meet the inclusion cri-
teria specified afterward and sign the informed consent
form (ICF).
An interim analysis will be performed on the primary
endpoint when 200 patients are enrolled and
randomized.
Inclusion criteria
 Able and willing to read, understand and provide
written informed consent
 Patients undergoing VATS lobectomy
 Age 18–80 years
 Gender: both
 Estimated life expectancy of at least 6 months.
 Tumor considered potentially resectable by R0
surgery
 Adequate respiratory function for surgery,
particularly a predicted postoperative (ppo) forced
expiratory volume in 1 s (FEV1) greater than 30%
and a ppo carbon monoxide lung diffusion capacity
(DLCO) greater than 30%, in addition to maximum
oxygen consumption greater than 10 ml/kg/min
 Must have signed and dated an ICF before performance
of any study-specific procedures or tests—subjects must
be fully informed about their illness and the investiga-
tional nature of the study protocol
Exclusion criteria
 Patients requiring ICU care with mechanical
ventilation
 Patients needing reintervention during postoperative
care
 Patients requiring a thoracotomy
 Tumor considered potentially resectable by
incomplete surgical resection with microscopic
residual disease (R1) or gross residual disease (R2)
Fig. 2 Trial flow chart. los length of stay
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 Evidence of extra-thoracic disease
 Major thoracic surgical procedure before enrollment
 Any other significant comorbid condition that, in
opinion of the investigator, would impair study
participation or cooperation
Screening
Subjects are screened prior to the surgery. The following
activities and/or assessments will be performed during
screening:
 Obtain written ICF from subject or subject’s legal
representative
 Collect subject’s medical history
 Record concomitant medications
 Perform physical examination
 Record vital signs, height and weight
 Collect blood sample for hematology, coagulation
tests, blood chemistry, renal and liver function tests
and measurement of electrolytes (obtain within 30
days prior to the surgery)
 Record 12-lead electrocardiogram (ECG)
 Record spirometry, hemogasanalysis and
bronchoscopy
 Perform baseline CT scan, PET–CT scan and chest
X-ray
 Perform anesthesiologic evaluation
Device description
The Drentech™ Palm EVO device is a portable vacuum
unit connected to a compatible collection system.
The collection system is a standard disposable drain-
age unit that can be connected to a chest drain, with a
water-seal valve.
The unit is capable of generating suction that can be
independently adjusted by a central vacuum and/or en-
ergy sources. The unit can be powered and/or the bat-
teries recharged using the power supply provided.
The mobile unit is equipped with a display to show
the following information:
 Indication of the “instantaneous” air leakage
corresponding to the last minute of operation
 Mean air leakage value of the patient in the last
hour of measurement
 Indication of the hours of device operation,
calculated starting from the moment of activation
 History of the air leakages and minimum and
maximum intrapleural pressures relating to the last
99 h of operation, available in numerical and graphic
form
 Measurement and storage of the minimum and
maximum intrapleural pressure values of the patient
relating to the last minute of operation
 Real-time measurement of the minimum and
maximum intrapleural pressure values for each
respiratory act of the patient
The unit can transfer data to a USB storage device in
order to view and/or store them on a PC. The USB stor-
age device can be connected to the dedicated port on
the unit using the adapter provided, and the data can be
viewed with standard spreadsheet programs or the
RedaxPlot software provided.
Randomization
A person not involved with either enrollment, assess-
ments or training of participants will generate the alloca-
tion sequence. Individual randomization, stratified for
centers and with blocking to reduce variability, will be
performed with a 1:1 allocation to the intervention and
control groups. The assignment to one of the two de-
vices will be performed using closed envelopes contain-
ing notes reading either “T” for traditional water seal
system or “D” for digital system. The randomization will
be done in the surgical theater at the end of thoraco-
scopic lobectomy by one of the surgeons by opening the
envelope assigned to the patient. Due to the nature of
the intervention, neither participants nor investigators
will be masked during the intervention.
Intervention
The day of the surgery, after induction of anesthesia, a
double-lumen endotracheal tube is used for selective
ventilation of the lungs. During the procedure, patients
are monitored by ECG, arterial line, pulse oximeter and
urine output. Patients are placed in a lateral decubitus
and undergo a VATS lobectomy associated with lymph-
adenectomy. During surgery, the patient receives fluid
and, eventually, blood replacement, maintaining ad-
equate blood pressure and urine volume. After VATS
lobectomy, the presence of air leaks is tested by a water
submersion test under standard airway pressure of 25
cm H2O and the air leaks are measured by a volumetric
system. In the case of significant air leaks (i.e. more than
100 ml/min), application of sutures is allowed, whereas
no buttressing material, sealants or pleural tents are
permitted. At the end of the procedure, a single apical
28-Ch chest tube is placed.
Patients are then randomized 1:1 to receive two differ-
ent types of chest drainage management: digital, con-
nected to the Drentech™ Palm Evo system; or traditional,
connected to the water-seal drain system already in use
in each center. After surgery, patients are transferred to
the ward.
Patients with the digital chest drainage system are
managed by setting the pump to − 20 cmH2O from the
moment the patient is extubated until the morning of
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the first postoperative day (POD) and then turning off
the suction (0 cmH2O). Patients with traditional devices
are connected to wall suction (− 20 cmH2O) until POD
1, and then they are disconnected from suction.
The following activities and/or assessments will be
performed after surgery:
▪ Daily assessment of the cardio-pulmonary parameters
(blood pressure, cardiac frequency, oxygen saturation)
all through the hospitalization
▪ Complete blood count, liver and renal functional tests
the first day after surgery and then depending on the
clinical condition of the patient or medical judgment
▪ Chest X-ray immediately after the return to the ward
and afterward depending on clinical condition of the
patient or medical judgment; after drains are removed,
another chest X-ray is performed before discharge
Postoperative treatments include respiratory rehabilita-
tion and mobilization, and antithrombotic and antibiotic
prophylaxis. Pain will be controlled by means of anal-
gesic drugs according to each center’s analgesic protocol
based on its routine practice (intravenous, epidural,
intercostal block or mixed regimens).
The chest tube is removed when chest X-rays show a
complete lung expansion and there is no detectable air
leak on traditional devices. For digital devices, absence
of air leaks is defined as a recorded airflow lower than
20ml/min, with suction set at 0 cmH2O, for at least 8 h
and without significant spikes of air leak on the graph.
The daily fluid drainage threshold for drain removal is
based on each center’s routine practice (generally 300
ml). During morning and evening rounds, the presence
of an air leak and the pleural effusion volume are
checked for both types of drain system. In particular, the
Drentech™ Palm Evo is equipped both with the standard
traditional “water-seal” system and with the digital elec-
tronic device: for the evaluation of correspondence be-
tween subjective clinical observation of air leaks and
objective digital results, the presence of air leaks will be
checked on each visit round by two clinicians via obser-
vation of bubbles in the chamber with the digital screen
switched off in order to be blinded regarding the digital
features. Then, the electronic screen is switched on and
the data are recorded. For the purpose of clinical man-
agement, in this group of patients, the clinician respon-
sible for the ward will consider only the features of the
digital device.
In the case of a “pleural space” effect suspected on the
basis of features of the digital system, a provocative
clamping maneuver will be performed and a control
chest X-ray at 24 h will be done for confirmation to de-
cide on chest drain removal. Air leak duration is calcu-
lated, as usual, from the day of operation until the day
an air leak is no longer detectable. Duration of air leaks
for more than 7 days are considered prolonged air leaks
and are managed according to each center’s routine (e.g.
discharge with a portable chest drainage system or reop-
eration). Moreover, in these cases, the air leak duration
will be measured and data will be collected until the 8th
POD and no discharge from the hospital will be consid-
ered before that day.
Follow-up
Postoperative follow-up will consist of a scheduled visit
with chest X-ray about 30 days after discharge.
Study termination and drop out
The patient has the right to terminate the research and
evaluation at any time point, without sacrificing further
medical treatment. There is no replacement of patients
who withdraw from the study or who interrupt prema-
turely. The reason for discontinuation of the study will
be given on the data collection form.
Statistical analysis
Periodical checking of the input data will be performed
in order to verify the completeness and consistency of
the database.
Checks on the consistency and plausibility of the re-
ported data will be carried out prior to data analysis.
The study is powered based on its primary endpoints:
the duration of chest tube placement and the length of
stay. The sample size was calculated to detect a differ-
ence in duration of chest tube placement and/or hospital
stay after thoracoscopic lobectomy of at least 1 day and
based on previously published data (standard deviation =
3) [5]. A sample size of 382 patients (191 patients per
group) was determined based on 90% statistical power,
with a significance level of 0.05, and allowing for
dropouts.
Risks and benefits for the patient
The patient’s participation in the study will not involve
additional risks other than those related to normal clin-
ical and surgical practice for pulmonary lobectomy. The
complications occurring after operation until discharge,
or within 30 days post operation in discharged patients,
are considered postoperative complications; death dur-
ing the same period is defined as perioperative death.
Postoperative complications are described according to
the Common Terminology Criteria for Adverse Events
4.1 (CTCAE version 4.1) published by the National
Cancer Institute of the USA, reported, classified and re-
corded in case report form (CRF).
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Data collection and management
The CRF of the study will be paper based (Additional file
2). Data will be collected at the time of patient enroll-
ment in the study, during hospitalization and at 1 month
after discharge.
All data collected will be recorded in a computer data-
base (Microsoft Excel) with the protection of a password.
A sequential identification number will be attributed to
each patient registered in the study. This number will
identify the patient and must be included on all case re-
port forms.
The database will be kept at the Thoracic Surgery Unit
of Padua University Hospital. The data will be collected
during the preoperative assessment, during surgery, in
the postoperative days during the daily evaluation of pa-
tients (at two visit rounds, in the morning and in the
afternoon) and at 1 month after discharge from the
hospital.
Discussion
Among patients undergoing pulmonary resection, the
postoperative management of chest tubes remains a crit-
ical issue. No standardized guidelines are available and,
particularly for air leakage assessment, tube management
conventionally depends on the experience of individual
surgeons; therefore, interobserver disagreement is fre-
quent [1, 2]. Finally, an apparent air leakage may be re-
lated to a pleural space effect and, in such cases, a
clamping trial should be performed to rule out the exist-
ence of small occult air leaks before removal [4].
To date, few studies have been performed to evaluate
the clinical impact of digital drainage systems [5–9, 12].
Previous published studies proved that electronic drain-
age systems reduce the interobserver variability, allowing
earlier removal of chest tubes and reducing the length of
hospital stay and costs [5, 11]. Brunelli et al. [5], in fact,
proved a decrease in LOS of 0.9 days (5.4 vs 6.3 days)
when comparing digital vs traditional systems, allowing
for a decrease in postoperative costs of €476 per patient
(€2391 vs €2867). Furthermore, Cerfolio and Bryant [11]
showed a decrease in LOS of 0.7 days (3.3 days vs 4.0
days) when comparing digital vs traditional systems, with
a mean day for chest tube removal of 3.1 vs 3.9 in favor
of the digital system. These studies underline the poten-
tial clinical utility and impact of electronic drainage sys-
tems; however, they have been performed using different
electronic devices—some of them use an air flow meter
to directly measure the airflow through the chest tube,
whereas others derive these data from an algorithm
based on the intrapleural pressure maintained by a suc-
tion pump and measured through a pressure sensor.
The proposed trial will provide new knowledge to this
research area by investigating and comparing the differ-
ence between digital and traditional chest drain systems,
evaluating not only clinical outcomes but also more the-
oretical issues that influence clinical practice.
Indeed, our aim is to determine not only whether the
use of a digital chest system compared with a traditional
system reduces the duration of chest drainage and LOS
as shown by the previous studies, but also to quantify
the variability of results regarding the subjective observer
evaluation of active air leaks (through the traditional sys-
tem) compared with the objective data registered by the
digital system by evaluating the daily presence of active
air leaks.
Another endpoint of our study is to identify any pre-
dictive factor of prolonged air leaks; however, these find-
ings will need further studies for their clinical validation.
Finally, among the patients enrolled in the digital sys-
tem group, we aim to explore the potentiality for
continuous monitoring of the intrapleural differential
pressure, the flow of air leak and the daily variation of
these two parameters, allowing us to distinguish an ac-
tive air leak from a pleural space effect by the evaluation
of intrapleural differential pressure and to identify po-
tential predictors of prolonged air leaks.
The results of this project will provide novel informa-
tion about the feasibility and usefulness of the digital
chest drain and can potentially provide new tools to
identify patients at higher risk of developing prolonged
air leaks.
Trial status
The study started in April 2017. The first patient was
enrolled on April 5, 2017. The study will continue until
sufficient power is reached, approximately until March
2020. Protocol version n. 3, February 15, 2017.
Supplementary information
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